A patient is undergoing intravenous chemotherapy treatment for uterine cancer. The patient's current regimen is to receive carboplatin, paclitaxel, and pembrolizumab as one cycle over 5 hours. Paclitaxel was infused over 3 hours, carboplatin over one hour, and pembrolizumab over 1 hour. What are the appropriate CPT codes to report in this scenario? ...
Subscribe or sign in to view the full article.
Article Overview
This article explains a coding scenario involving intravenous chemotherapy administration for uterine cancer and focuses on how a multi-agent infusion session is reported in CPT. It is intended for coders, billers, and oncology revenue cycle staff who need to understand the structure of infusion coding for a single treatment visit. The content centers on the timing and sequencing of therapy within the visit and identifies the CPT codes associated with the scenario.
Why This Topic Matters
Accurate reporting of complex infusion visits is important for oncology coding compliance, claim integrity, and consistent charge capture for chemotherapy administration services.
What You Will Learn
- How a multi-drug chemotherapy infusion encounter is organized for coding review
- How CPT infusion administration concepts are applied to a single treatment session
- How infusion timing and sequencing are reflected in the coding discussion
- Which general coding considerations are highlighted for oncology infusion services
Who Should Read This
- Medical coders
- Oncology billing staff
- Revenue cycle professionals
- Clinical documentation specialists
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com